Merle Friederike Fenner

Merle Friederike Fenner

Auto-generated profile, based on publicly available information

Merle Friederike Fenner

Department of Veterinary Clinical Sciences, Faculty of Health and Medical Sciences University of Copenhagen Taastrup Denmark

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 October 2019 in BMC Cardiovascular Disorders
Verified
Journal Article
Open access
PDF file
EHEva Zander Hesselkilde
Eva Zander Hesselkilde
HCHelena Carstensen
Helena Carstensen
MFMette Flethøj
Mette Flethøj
MFMerle Fenner
Merle Fenner
DKDitte Dybvald Kruse
Ditte Dybvald Kruse
RBRikke Buhl
Rikke Buhl
Background: Large animal models are important in atrial fibrillation (AF) research, as they can be used to study the pathophysiology of AF and new therapeutic approaches. Unlike other animal models, horses spontaneously develop AF and could therefore serve as a bona fide model in AF research. We therefore aimed to study the electrical, functional and structural remodelling caused by chronic AF in a horse model. Method: Nine female horses were included in the study, with six horses tachypaced into self-sustained AF and three that served as a time-matched sham-operated control group. Acceleration in atrial fibrillatory rate (AFR), changes in electrocardiographic and echocardiographic variables and response to medical treatment (flecainide 2 mg/kg) were recorded over a period of 2 months. At the end of the study, changes in ion channel expression and fibrosis were measured and compared between the two groups. Results: AFR increased from 299 ± 33 fibrillations per minute (fpm) to 376 ± 12 fpm (p < 0.05) and atrial function (active left atrial fractional area change) decreased significantly during the study (p < 0.05). No changes were observed in heart rate or ventricular function. The AF group had more atrial fibrosis compared to the control group (p < 0.05). No differences in ion channel expression were observed. Conclusion: Horses with induced AF show signs of atrial remodelling that are similar to humans and other animal models.

1 July 2018 in Journal of Veterinary Internal Medicine
Verified
Journal Article
Open access
PDF file
RBRikke Buhl
Rikke Buhl
HCHelena Carstensen
Helena Carstensen
EHEva Zander Hesselkilde
Eva Zander Hesselkilde
BKBjørg Zinkernagel Klein
Bjørg Zinkernagel Klein
KHKaren Margrethe Hougaard
Karen Margrethe Hougaard
TJThomas Jespersen
Thomas Jespersen
Background Atrial fibrillation (AF) is the most common arrhythmia affecting performance in horses. However, no previous studies have quantified the performance reduction in horses suffering from AF. Objectives To quantify the effect of AF on maximum velocity (Vmax), maximum heart rate (HRmax), heart rate recovery (T100), hematologic parameters and development of abnormal QRS complexes. Animals Nine Standardbred trotters. Methods Two‐arm controlled trial. Six horses had AF induced by means of a pacemaker and 3 served as sham‐operated controls. All horses were subjected to an exercise test to fatigue before (SET1) and after (SET2) 2 months of AF or sham. The Vmax and HRmax were assessed using a linear mixed normal model. Abnormal QRS complexes were counted manually on surface ECGs. Results Atrial fibrillation resulted in a 1.56 m/sec decrease in Vmax (P < .0001). In the AF group, HRmax ± SD increased from 226 ± 11 bpm at SET1 to 311 ± 27 bpm at SET 2. The AF group had higher HRmax at SET2 compared with controls (P < .0001), whereas no difference between the control and AF groups was observed at SET1 (P = .96). Several episodes of wide complex tachycardia were observed during exercise in 3 of the AF horses during SET2. Conclusions and Clinical Importance Atrial fibrillation resulted in a significant reduction in performance, an increase in HR and development of abnormal QRS complexes during exercise, which may be a risk factor for collapse or sudden cardiac death.

20 May 2020 in British Journal of Pharmacology
Verified
Journal Article
Closed access
PDF file
MFMerle Friederike Fenner
Merle Friederike Fenner
HCHelena Carstensen
Helena Carstensen
SNSarah Dalgas Nissen
Sarah Dalgas Nissen
EHEva Melis Hesselkilde
Eva Melis Hesselkilde
CLChristine Scott Lunddahl
Christine Scott Lunddahl
RBRikke Buhl
Rikke Buhl

1 September 2021 in Theriogenology
Verified
Journal Article
Open access
VNVahid Najafzadeh
Vahid Najafzadeh
JSJan Bojsen-Møller Secher
Jan Bojsen-Møller Secher
MPMaria Pihl
Maria Pihl
AÆAnna Ærenlund
Anna Ærenlund
NJNatasha Jørgensen
Natasha Jørgensen
PHPoul Hyttel
Poul Hyttel
Vitrification and slow freezing are the two commonly used embryo cryopreservation methods. In most studies, vitrification of intact embryos has proven superior in several respects, including cell and embryo survival and pregnancy rate. However, there is a lack of data for comparing these two methods in in vitro produced (IVP) bovine blastocysts, which have been subjected to the retrieval of trophectoderm (TE) biopsy. Day 7 IVP blastocysts were pooled and randomized into four groups: 1) non-biopsy (NB), 2) biopsy (B), 3) biopsy-vitrification (BV), 4) biopsy-slow freeze (BSF). The blastocysts in the B, BV, and BSF groups were subjected to TE biopsy. For the B group, this was followed by 5 hours (h) incubation and subsequent scoring of the biopsy-survival (re-expansion) rate before processing for further analyses. For the BV and BSF groups, the biopsy procedure was followed by 2 h incubation, allowing for a quick re-expansion, after which the blastocysts were subjected to vitrification and slow freezing, respectively. After warming and thawing, respectively, they were then incubated for 5 h followed by scoring the cryo-survival (re-expansion) rates before processing for further analyses. These included quantification of ICM and TE cells, cleaved caspase-3- and TUNEL-positive cells, quantitative PCR on cellular stress markers (SOD1 and PRDX1), and ultrastructural analysis. The biopsy-survival rate in the B group was 94% (307/326). The cryo-survival rate in BV (86%, 138/161) was higher than that in BSF (57%, 81/142; P < 0.001). No differences were noted between the average ICM, TE, and total cell numbers of the groups. The percentages of cleaved caspase-3-positive cells were higher in BV vs. NB (P < 0.05), in BSF vs. NB (P < 0.001), and in BSF vs. B (P < 0.001). The percentages of TUNEL-positive cells were higher in BV vs. NB (P < 0.05) and in BSF vs. NB (P < 0.001). The levels of mRNA abundance for SOD1 and PRDX1 in B, BV, and BSF were not different from that in NB. The ultrastructural analysis of blastocysts in the BV and BSF groups showed distension of extracellular spaces and appearance of intracellular vacuoles in the ICM, distension of mitochondria, and disorganization of mitochondrial cristae in both ICM and TE, and weakened tight junctions between adjacent TE cells. In summary, our findings demonstrate that vitrification yields a higher cryo-survival rate than slow freezing in biopsied bovine IVP blastocysts. However, biopsy-vitrification and biopsy-slow-freeze values are comparable in terms of ICM, TE, and total blastocyst cell numbers, as well as cleaved caspase-3- and TUNEL-positive cell rates. Moreover, biopsy and cryopreservation performed alone had no effect on ICM, TE, total blastocyst cell numbers, or TUNEL-positive cell rates. Biopsy and vitrification performed alone had no effect on the cleaved caspase-3 positive cell rates, whereas slow freezing resulted in an increased rate. Furthermore, double traumatization with a combination of biopsy and cryopreservation, either vitrification or slow freezing, resulted in increased rates of cleaved caspase-3- and TUNEL-positive cells.

20 April 2018 in Equine Veterinary Journal
Verified
Journal Article
Closed access
PDF file
MFM. F. Fenner
M. F. Fenner
DVDenis Verwilghen
Denis Verwilghen
NTN. Townsend
N. Townsend
HSH. Simhofer
H. Simhofer
JSJ. Schwarzer
J. Schwarzer
ABA. Bienert‐Zeit
A. Bienert‐Zeit

22 August 2018 in Journal of Veterinary Internal Medicine
Verified
Journal Article
Open access
PDF file
HCHelena Carstensen
Helena Carstensen
EHEva Z. Hesselkilde
Eva Z. Hesselkilde
MFMerle Fenner
Merle Fenner
ALAmeli V. Loft-Andersen
Ameli V. Loft-Andersen
MFMette Flethøj
Mette Flethøj
RBRikke Buhl
Rikke Buhl
Background Pharmacological treatment of atrial fibrillation (AF) in horses can be challenging because of low efficacy and adverse effects. Flecainide has been tested with variable efficacy. Objective To test whether the efficacy of flecainide is dependent on AF duration. Animals Nine Standardbred mares. Methods Factorial study design. All horses were instrumented with a pacemaker and assigned to a control or an AF group. On day 0, all horses were in sinus rhythm and received 2 mg/kg flecainide IV. Atrial fibrillation subsequently was induced in the AF group by pacemaker stimulation. On days 3, 9, 27, and 55, flecainide was administered to all horses, regardless of heart rhythm. Results All horses in AF cardioverted to sinus rhythm on days 3 and 9. On day 27, 5/6 horses cardioverted, whereas only 2/6 cardioverted on day 55. The time from the start of flecainide infusion to cardioversion (range, 3–185 min, log transformed) showed linear correlation with the cumulative duration of AF (r2 = .80, P < .0001). Flecainide induced abnormal QRS complexes in 4/6 AF horses and 1/3 controls. A positive correlation was found between heart rate before flecainide infusion and number of abnormal QRS complexes (0.14, P < .05). One horse suffered from cardiac arrest and died after flecainide infusion. Conclusions and Clinical Importance Flecainide is effective for cardioversion of short‐term induced AF, but the effect decreases with AF duration. Controlling heart rate may minimize adverse effects caused by flecainide, but the drug should be used with great caution.